COMP <GO>
MYO vs JNJ // ENTERPRISE SCALE & MARKET CAP
Myomo Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: MYO 1
— JNJ 8
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $1.30 (+3.18%) • MKT CAP: $51.5M
market-cap
$51.5M
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MYO VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MYO | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 65.70% | 67.90% | -2.20 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.50% | -60.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.97% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -35.20% | 34.70% | -69.90 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -38.10% | 28.50% | -66.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 25.70% | 6.00% | +19.70 | MYO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.59 | -5.39 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.9 | 62.1 | -14.20 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $51.5M | $662.49B | -$662.44B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MYO REV | JNJ REV | MYO GROSS % | JNJ GROSS % | MYO FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.9M | $94.19B | 65.7% | 67.9% | -$16.3M | $19.70B |
| FY 2024 | $32.6M | $88.82B | 71.2% | 69.1% | -$4.7M | $19.84B |
| FY 2023 | $19.2M | $85.16B | — | — | -$6.2M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MYO // BETA —
JNJ // BETA 1.08